Drug Name DARZALEX® (daratumumab) Drug Class Immunosuppressant Risk minimization type Direct Healthcare Professional Communication DHPC Specialty (Theraputic area) Oncology Risk Incorrect information about solution concentration in Arabic section of the outer pack. Dear Healthcare provider letter DHPC